ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $302K of Arcutis Biotherapeutics, Inc.
Sold$302,133
$30.21Price
10,000Shares
−11%Stake
What ARQT did after the filing
- The stock from Thu, Dec 4 open, $29.37
- −11.9%
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 20 close.
Traded Mon, Dec 1. Filed Wed, Dec 3, 5:23 PM ET, after the close. Returns use the Dec 4 open and the Jan 20 close. Not investment advice.